CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 24 enrolled
Drug / intervention
Dayspring Active Wearable Compression Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04897035
NCT04897035N/ACompleted

A Non-randomized, Open-Label Study to Evaluate the Safety and Effectiveness of Dayspring Active Wearable Compression Technology for Treating Lower Extremity Lymphedema

Koya Medical, Inc.·interventional·Posted May 21, 2021·Updated Feb 17, 2026

In Brief

A clinical study evaluating Dayspring Active Wearable Compression System for Lymphedema and 3 related conditions. Completed, enrolled 24 participants across 2 sites.

Detailed Summary

A Non-randomized, Open-Label Study to Evaluate the Safety and Effectiveness of Koya Dayspring Active Wearable Compression Technology for Treating Lower Extremity Lymphedema

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedMay 21, 2021
Enrollment StartJun 1, 2021
Primary CompletionJun 30, 2022
Study CompletionJul 1, 2022
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 5.1 years ago

Interventions

Dayspring Active Wearable Compression Systemdevice

Dayspring Active Wearable Compression System